Clinic Stablishes Nanotherm Therapy for the Treatment of Recurrent Brain Tumors, Berlin University Reveals
Published: Jul 08, 2011
Universitätsmedizin Berlin has established a new treatment at the Clinic for Radiooncology, Campus Virchow, which offers selected patients a nanomedicine approach for the treatment of recurrent brain tumors. Researchers at Charité–developed the scientific basis for the nanotechnology-based cancer therapy. The clinical trial supporting the therapy's European approval was also conducted in close collaboration with the Charité. MagForce Nanotechnologies AG, a Charité spin off company, is marketing the therapy.